New Jersey Transit
Home > About Us >

NEW JERSEY TRANSIT CORPORATION

NJ TRANSIT BUS OPERATIONS, INC.

NJ TRANSIT RAIL OPERATIONS, INC.

NJ TRANSIT MERCER, INC.

NJ TRANSIT MORRIS, INC.

REGULARLY SCHEDULED BOARD OF DIRECTORS’ MEETINGS

JANUARY 11, 2017

FINAL AGENDA

Ø CALL TO ORDER

Ø SAFETY ANNOUNCEMENT

Ø PLEDGE OF ALLEGIANCE TO THE FLAG

Ø APPROVAL OF MINUTES OF PREVIOUS MEETINGS

Ø PUBLIC COMMENTS ON AGENDA ITEMS AND OTHER MATTERS

Ø ADVISORY COMMITTEE REPORT

Ø SENIOR CITIZEN AND DISABLED RESIDENT TRANSPORTATION ADVISORY COMMITTEE REPORT

Ø BOARD COMMITTEE REPORTS

Customer Service Committee

Administration Committee

Capital Planning, Policy & Privatization Committee

Ø EXECUTIVE DIRECTOR’S MONTHLY REPORT


ACTION ITEMS


ITEM 1701-01:         EXTENSION OF HEALTHCARE CARRIER CONTRACT: HORIZON BLUE CROSS/BLUE SHIELD OF NEW JERSEY

Authorization to extend NJ TRANSIT Contract No. 10-120 with its current healthcare carrier, Horizon Blue Cross/Blue Shield of New Jersey, including Medical, Dental, Managed Mental Health, and Flexible Spending administration at rates lower than current, for a period of one year, beginning January  1, 2017,  to ensure continuation of coverage for NJ TRANSIT employees and retirees and eligible dependents with administrative costs not to exceed $5,600,000 per year, and with two (2), one-year renewal options, subject to future Board approval, not to exceed a total of $16,800,000, subject to the availability of funds through December 2019.        

 

ITEM 1701-02:         EXTENSION OF PRESCRIPTION DRUG CARRIER CONTRACT: EXPRESS SCRIPTS  

Authorization to extend NJ TRANSIT Contract No. 10-121 with its current prescription drug carrier, Express Scripts, Inc., for a period of one year, beginning January 1, 2017, to ensure continuation of coverage for NJ TRANSIT with administrative costs not to exceed $167,000 per year, and with two, one-year renewal options, subject to future Board approvals, not to exceed a total of $501,000, through December 2019.        

 

EXECUTIVE SESSION AUTHORIZATION: Discuss personnel matters, contract negotiations, the status of pending and anticipated litigation and matters falling within the attorney-client privilege.


ITEM 1701-03:       ADVANCED SPEED ENFORCEMENT SYSTEM II – POSITIVE TRAIN CONTROL: AMENDMENT TO IMPLEMENTATION CONTRACT       

Authorization to amend NJ TRANSIT Contract No. 10-099X with Parsons Transportation Group of New York, New York, for Phases I, II and III of the ASES II PTC Program at a cost not to exceed $32,500,000, for a total contract authorization of $205,904,120, subject to the availability of funds.    

 

Ø ADJOURNMENT

 

To view the detailed version of this final Board Agenda, click here